ホーム > 主な業績

基礎研究

Koarada S, Tashiro S, Nagao N, Suematsu R, Ohta A, Tada Y
Increased RP105-Negative B Cells in IgG4-Related Disease.
The Open Rheumatology Journa 2013;7: 55-57

Koarada S, Tada Y.
RP105-negative B cells in systemic lupus erythematosus.
Clin Dev Immunol 2012; 2012: 259186.

Koarada S, Tada Y, Suematsu R, Soejima S, Inoue H, et al.
Phenotyping of RP105-negative B cell subsets in patients with systemic lupus erythematosus.
Clin Dev Immunol 2012; 2012: 198206.

Tada Y, Kondo S, Aoki S, Koarada S, Inoue H, et al.
Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice.
Arthritis Rheum 2011; 63: 738-748.

Koarada S, Tada Y, Sohma Y, Haruta Y, Suematsu R, et al.
Autoantibody-producing RP105(-) B cells, from patients with systemic lupus erythematosus, showed more preferential expression of BCMA compared with BAFF-R than normal subjects.
Rheumatology 2010; 49:662-670.

Tada Y, Koarada S, Morito F, Mitamura M, Inoue H, et al.
Toll-like receptor homolog RP105 modulates the antigen-presenting cell function and regulates the development of collagen-induced arthritis.
Arthritis Res Ther 2008; 10(5): R121.

Haruta Y, Koarada S, Tada Y, Mitamura M, Ohta A, et al.
High expression of Toll-like receptor 4 on CD14+ monocytes in acute infectious diseases.
Scand J Infect Dis 2007; 39: 577-583.

Koarada S, Haruta Y, Mitamura M, Morito F, Tada Y, et al.
Ex vivo CD4+ T-cell cytokine expression from patients with Sjogren’s syndrome following in vitro stimulation to induce proliferation.
Rheumatology 2006; 45: 392-399.

Tada Y, Koarada S, Tomiyoshi Y, Morito F, Mitamura M, et al.
Role of inducible costimulator in the development of lupus in MRL/lpr mice.
Clin Immunol 2006; 120: 179-188.

臨床研究

Suematsu R, Ohta A, Matsuura E, Takahashi H, Fujii T, et al.
Therapeutic response of patients with adult Still’s disease to biologic agents: multicenter results in Japan.
Mod Rheumatol 2012; 22:712-719

Tada Y, Suematsu E, Ueda A, Nagano S, Sawabe T, et al.
Clinical factors to predict a poor prognosis and refractory disease in patients with polymyositis and dermatomyositis associated with interstitial lung disease.
Clin Exp Rheumatol 2012; 30:450

Matsuura E,  Ohta A, Suematsu R, Inoue H, Koarada S, et al.
Functional disturbance in stress-adaptation system in patients with scleroderma.
Mod Rheumatol 2011; 21: 397-405

Koarada S, Tsuneyoshi N, Haruta Y, Tada Y, Mitamura M, et al.
Effect of disease activity and corticosteroids on serum levels of soluble endothelial cell protein C receptor in patients with systemic lupus erythematosus.
Mod Rheumatol 2009; 19: 173-179.

Mitamura M, Tada Y, Koarada S, Inoue H, Suematsu R, et al.
Cyclosporin A treatment for Japanese patients with severe adult-onset Still’s disease.
Mod Rheumatol 2009; 19: 57-63.

Nagasawa K, Tada Y, Koarada S, Tsukamoto H, Horiuchi T, et al.
Prevention of steroid-induced osteonecrosis of femoral head in systemic lupus erythematosus by anti-coagulant.
Lupus 2006; 15: 354-357.

Tada Y, Koarada S, Haruta Y, Mitamura M, Ohta A, et al.
The associatin of Behcet’s disease with myelodysplastic syndrome in Japan: A review of the literature.
Clin Exp Rheumatol 2006; 24: S115-119.

書籍

Koarada S, Tada Y
Fundamental Rheumatological Knowledge of Arthritis Images of the Hand and Case Studies for General Physicians (Medical Procedures, Testing and Technology)